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Abstract
Background and Purpose: The guidelines set forth by the American Physical Therapy
Association (APTA) contraindicate exercise when hemoglobin blood values are <8 g/dL,
platelets are <20,000/mL, or white blood cells (WBCs) are <5,000/mm3 accompanied by
a fever. The purpose of this study was to determine if APTA hematological guidelines are
appropriate for determining activity levels in children undergoing chemotherapy. The
guidelines were initially established for patients with acute changes in blood values, but it
has been questioned if these guidelines are appropriate for populations with chronically
low blood values such as children with cancer.
Methods: A retrospective chart review was done using a consecutive sample of children
with cancer being seen for physical therapy (PT) while undergoing chemotherapy. A
maximum of four PT sessions per child were included for a total of 201 chart reviews.
Subject’s hemoglobin, platelet, and WBC values were recorded within 24 hours of a PT
session. Interventions and modifications to PT treatment were documented. The patient’s
chart was reviewed for two days following the PT visit and any critical incidences as
defined by the researchers were recorded.
Results: Participants included 33 males and 40 females ranging in age from 3 to 18, with
a mean age of 9.5 years. The most common cancer diagnoses were acute lymphoblastic
leukemia, Wilms’ tumor, and osteosarcoma. A Fisher’s exact test showed no significant
relationship between low hemoglobin, low platelets, or low WBCs and number of critical
incidences (2.56, p = 0.196; 0.198, p = 0.776; 0.501, p = 0.444 respectively). A risk ratio
of critical incidences in patients with low blood values versus normal blood values was
ii

found to be 4.3 (CI 0.58 – 32.30) for low hemoglobin, 0.79 (CI 0.29 – 2.20) for low
platelets, and 0.64 (CI 0.19 – 2.17) for low WBCs.
Conclusion: Results suggest there was no statistically significant evidence indicating
children with chronically low platelets or WBCs were at greater risk for incidences when
compared to normal values.

In patients with low hemoglobin values there was an

increased risk for minor events such as tachycardia. This supports our original hypothesis
that a symptom-based approach in determining appropriateness for PT may be utilized in
populations experiencing chronically low blood values.
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Chapter I
Introduction: Literature Review
When deciding whether or not it is safe to work with a patient, a review of lab
values is performed to rule out any critical values that may caution or contraindicate
mobilization of a critically ill patient. According to the guidelines put together by the
acute care section of the American Physical Therapy Association (APTA) for
hematological blood values in particular, these values include: normal white blood cell
(WBC) count 4,500-11,000/mm3 in adult males and females, normal platelet count of
150,000-350,000/microL in adult males and females, and normal hemoglobin (Hgb) 14.416.6 g/dL in adult males and 12.2-14.7 g/dL in adult females.1 Within the article that
outlines these normal values it is suggested that therapists do not proceed with exercise if
WBC count is less than 5,000/mm3 and is accompanied by a fever, if Hgb is less than 8
g/dL, or if platelets are less than 20,000/microL.1
These guidelines are ambiguous when it comes to pediatric clients. Pediatric
values were not specified in any APTA acute care document, however it was noted that
they will vary from birth to 15 years old. An online pediatric care resource outlines that
normal WBC count in children ranges from 5,500-15,500/mm3 for those two to five years
of age, 5,000- 14,500/mm3 for those five to eight years, 4,500-13,500/mm3 for those nine
to twelve years of age, and 4,500-13,000/mm3 in those 13 to 18 years of age.2 Platelets
should range from 150,000-550,000/mm3, and hemoglobin should be within 11.5 to 15.5
(g/dL).2 Children’s Hospitals and Clinics of Minnesota, the site at which this particular
study was conducted, follow these guidelines for WBC count and hemoglobin, with the
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exception of 13-16 g/dL as normal hemoglobin for males and 12-16 g/dL as normal for
females in the 13-18 year age range. Normal platelets for a child of any age at Children’s
Hospital of Minnesota range from 250,000-450,000/mm.3
Although the guidelines have been in place for many years, evidence for their use
is lacking. In fact, no randomized controlled trials were used to establish these normative
values. The lab value guidelines given for adults were compiled by a task force of the
Acute Care section of the national APTA. They used several acute care textbooks for
physical therapists, guides on the interpretation of laboratory tests and critical lab values,
and lab value reference books to determine their guidelines.3

Examining statistics

however, may provide further explanation of how these normal values came into
existence.
Erstad4 notes that “normal” lab values are determined by whether the value falls
within a normal, bell-shaped curve. He notes that there are people outside of two
standard deviations from the mean of a lab value who are still considered healthy
individuals. He cautions, along with authors from several other articles, that laboratory
values should not be examined in isolation.1,4,5,6,7 People have died with “normal” lab
values, and people have lived perfectly normal lives with “abnormal” lab values. In
addition lab values considered “abnormal” may be “normal” for a particular patient.
Irion5 states in his article that therapists should “…use good clinical judgment,
communication with other healthcare providers, and monitor[ing] the responses of
patients to therapy, rather than follow published guidelines.” Thus, there is a consensus
among the articles reviewed that laboratory values should not stand alone in determining
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whether or not to mobilize a patient, but instead many other factors should also be
considered.5,6,7
Stiller et al.6,7 suggests many ways therapists may decide if a patient is safe to be
mobilized, including objective and subjective factors. Objective factors include heart rate
(HR), blood pressure (BP), rate pressure product (RPP), cardiac status, oxygenation,
respiratory pattern, presence of mechanical ventilation, hemoglobin, platelet count, white
blood cell count, fever, and blood glucose level. Subjective considerations include the
patient’s facial expression, emotional state, level of pain, level of anxiety, pallor, rate of
perceived exertion (RPE), diaphoresis, and overall physical appearance. Other factors
that should be included are whether the patient has any orthopedic precautions, level of
cognition, incisions, risk or presence of deep vein thrombosis, nutritional status, as well
as the presence of various lines and tubes. These guidelines in conjunction with clinical
judgment, reasoning, and experience should help in determining when critically ill
patients are appropriate for mobilization.12,13,15
There are many physiological reasons behind why we may not mobilize a patient
with abnormal blood values.

These abnormal blood values are indicative of blood

disorders in patients with cancer as the result of chemotherapy and the presence of
tumors.1 Disorders include anemia, leukocytosis, leucopoenia, and thrombocytopenia.
Each of these disorders has different implications for therapy when initiating
mobilization of the critically ill patient.
Children with cancer, specifically leukemia or lymphoma (two of the most
common types), have an increased risk of developing low hemoglobin. This is in part
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due to the destruction of red blood cells when these diseases cause the immune system to
produce anti-bodies that clump red blood cells together. These clumps of red blood cells
are then recognized by the body as foreign and are destroyed.8 These and other pediatric
cancers also often attack the child’s bone marrow where red blood cells are made and
replace it with fibrotic tissue, or radiation destroys bone marrow stem cells.8
Chemotherapy drugs also can lower the amount of healthy blood cells, as these drugs are
cytotoxic and not specific to only the tumor cells.8
Hemoglobin is the predominant oxygen-carrying protein within red blood cells.
A low red blood cell count due to a change in the quantity or quality of red blood cells
and thus a decrease in the oxygen carrying capacity of the blood is defined as anemia. 8
Therefore, low levels of hemoglobin correspond with a decreased amount of oxygen
available to the tissues of the body and often result in anemia.
Exercising a patient with anemia places increased oxygen demands on the body
and causes the heart rate to increase. An increase in heart rate can lead to tachycardia,
with accompanying fatigue, generalized weakness, loss of stamina, and shortness of
breath.8 Tachycardia can lead to dysrhythmias, which rarely but sometimes can lead to
sudden cardiac arrest.8 One study by Unverferth et al. found an increase in cardiac
dysrhythmias recorded on a Holter monitor for patients with cancer who exerted
themselves two to six hours following chemotherapy.9 This study recommended patients
undergoing chemotherapy do not exercise within two to six hours following treatment.
One way to determine whether or not a patient has anemia and the severity of
anemia is to examine hemoglobin values. Exercise is contraindicated if Hgb is below 8
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g/dL. Light exercise is permitted if Hgb ranges from 8-10 g/dL, and Hgb >10 allows for
the patient to attempt resistive exercise according to APTA guidelines.1
Leukocytosis is the presence of high levels of white blood cells (> 11,000/mm 3),
indicating likely presence of infection or fever.1,5,6 Acute infections and fever often place
greater oxygen demands on the body, and therefore, it is important to carefully monitor
oxygen saturation levels, respiratory rate, and rate of perceived exertion during therapy.
Leucopenia is the result of an abnormally low WBC count (< 5,000/mm3), often
due to the toxic effect chemotherapy drugs have on these cells. A patient with a low
white blood cell count may be at an increased risk for infection and fevers, leading to
increased oxygen demands on the body; thus requiring the same precautions as above.7,8
According to the APTA guidelines, if the WBC count is less than 5,000/mm3 and
accompanied by a fever, exercise is contraindicated. If WBC count is greater than
5,000/mm3 the patient can participate in light exercise, which can progress to resistive
exercise.1
Thrombocytopenia is low platelets (< 150,000/microL) in the blood, indicating an
increased risk for spontaneous bleeding and decreased ability for the bleeding to clot.
Platelets are also made in the bone marrow and can be destroyed by chemotherapy and
radiation. Patients with very low platelet counts are at high risk for vascular trauma and
bleeding as a result of activity or significant increases in blood pressure.12,13 Patients with
this disorder may present with ecchymosis or purpura spots. According to the APTA
guidelines, exercise is contraindicated in patients with a platelet count of less than
20,000/microL. Between 20,000 and 50,000/microL light exercise such as active range
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of motion is permitted. If the platelet count is greater than 50,000/microL, resistive
exercises can be attempted.1, 7
APTA Exercise Guidelines
Hemoglobin:
<8: No exercise permitted
8-10: Light exercise permitted
>10: Resistive exercises permitted
Platelet Count:
<20,000: No exercise
20,000-50,000: Light exercises (no PROM, but light AROM is
permitted)
>50,000: Resistive exercises permitted
WBC:
<5000 with fever: No exercise permitted
>5000: Light exercise, progress to resistive exercise permitted

Research and data regarding the risks of exercise and mobility for patients with a
cancer diagnosis suffering from the above blood disorders continue to be lacking.8 Some
physicians recommend abstaining from or minimizing amounts of physical exercise due
to the increased risk of bleeding and tissue damage in patients with low hemoglobin and
platelet blood counts. However, according to Stiller et al.6 chronically low blood values
for a particular patient should be treated differently than an acute change. Chronically
low blood values may be seen with some kinds of chronic diseases, such as chronic renal
failure.7 If a patient has been living stably with chronically abnormal lab values it has
been the practice of many physicians to allow physical activity in order to prevent the
deleterious results of bed rest and inactivity. These deleterious effects include: muscle
weakness, decreased muscle endurance, negative nitrogen balance, pneumonia,
thrombosis, kidney stones, increased diuresis, orthostatic hypotension, cardiovascular
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deconditioning, skin breakdown, depression, fatigue, and decreased quality of life.10
Therefore, it is important to weigh the possible risks and benefits of exercising a critically
ill patient with abnormal blood values. There is a large body of research that has come
out in the past two decades which highlights the benefits of exercise for critically ill
patients, including our area of interest, patients with cancer.
To date medical professionals continue to debate the possible positive or negative
effects exercise has on patients diagnosed with cancer.14 As mentioned above, it has been
theorized that vigorous exercise may be harmful for patients with cancer; however, no
literature supports this notion. In a review of literature regarding early exercise therapies
for patients with a cancer diagnosis, 16 of out 18 intervention studies and five out of six
descriptive studies documented statistically significant results for various quality of life
outcome measures. Four meta-analyses and two systemic reviews on the effects of
exercise and aerobic capacity, fatigue, and quality of life in patients with cancer were also
found.19 The meta-analyses and systemic reviews on exercise and patients with cancer
revealed 12 studies on exercise capacity, 14 on fatigue, and 19 studies regarding the
physical quality of life. Nine randomized control trials looked at the effects of exercise
training on muscle strength. A large amount of evidence from these studies supports the
positive effects of exercise on physiological outcomes during and after cancer
treatments.19 We were unable to find any studies examining the effects of exercise on
children with cancer specifically, yet there are many studies of adult cancer populations
that show exercise is beneficial, and therefore is likely beneficial in pediatric populations
as well.
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In accordance with the evidence that shows physical activity to have a positive
impact on function, quality of life, and improving psychosocial well-being in patients
with cancer undergoing treatment, the studies also revealed that increased physical
activity after a cancer diagnosis reduces the risk of cancer reoccurrence and mortality.19
The literature has consistently shown that physical exercise following a cancer
diagnosis improves quality of life.16 Many of the physical and functional deficits as a
result of cancer and its treatment are impacted by therapeutic interventions including
exercise.16,19 The literature also shows that exercise during and/or following cancer
treatments prevents decline and can improve cardio-respiratory function, body
composition, immune function, strength and flexibility, body image, self-esteem, and
mood. Exercise can also decrease the number and severity of side effects, decreasing
duration of hospitalization, and improving the likelihood for completion of chemotherapy
treatment. Similar to findings by vanWeert et al.19 the psychosocial benefits of exercise
in patients with cancer include better adjustment to illness, reduction of stress, and
decreased rates of depression and anxiety.20
Fatigue is one of the most common symptoms experienced after high dose
chemotherapy, occurring in 70-90% of patients with cancer.11,13 Patients describe fatigue
as one of the most difficult symptoms to deal with during chemotherapy treatments, even
more distressing than pain, nausea, or vomiting. The fatigue experienced is typically
thought to be due to cancer related anemia from decreased hemoglobin levels as a result
of chemotherpay.11,13 As previously mentioned, when a patient is experiencing anemia
inadequate amounts of oxygen are being delivered to peripheral tissues. This in turn can
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lead to breathlessness, tiredness, and extreme fatigue. Other disadvantages of anemia
include the need for blood transfusions, diminished energy, lethargy, sexual dysfunction,
impaired concentration, impaired memory, and a decline in intellectual ability. This can
lead to decrease in a patient’s quality of life and reduce the motivation and desire to
participate in exercise.12
The National Cancer Institute defines mild anemia as hemoglobin levels of 10-11
g/dL. Moderate anemia is defined to be hemoglobin levels between 8-9.9 g/dL, and
severe anemia as 6.5-7.9 g/dL.11 Mild-moderate anemia, although important to note,
rarely has a negative impact on a patient’s mortality, but has been associated with
decreased quality of life and functional status.
As recommended by the APTA,1 patients with hemoglobin levels between 8-10
g/dL are permitted to participate in light exercise. As physical therapists, this is an ideal
time to help improve the quality of life and function of patients receiving chemotherapy
and experiencing anemia. Evidence has shown that sedentary patients with breast cancer
who have a reduced exercise tolerance report higher degrees of fatigue during
chemotherapy treatments when compared to more active, physically fit patients.13
Exercise offers the strongest evidence for relieving cancer related fatigue.2 There
have been 11 published reports by four different research groups testing the impact
exercise has on fatigue during high dose chemotherapy. Two additional studies have
looked at the effects of exercise on patients after treatment has been completed. All 13
studies indicate significantly lower levels of fatigue in patients who exercised compared
to sedentary controls.13 Additional evidence has found physically active patients with
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cancer to have lower resting heart rates, lower blood pressure, more energy, increased
muscle strength, and improved restful sleep.

Many patients undergoing high dose

chemotherapy experience feelings of depression, stress, and anxiety.20 Using exercise as
part of rehab can help improve some of the negative psychosocial aspects often
accompanying a cancer diagnosis. Although the benefits of exercise in patients with
cancer related fatigue have been shown to be consistent across studies, the studies are
limited in number of participants, methodology, and often only include women with
breast cancer.13
The research shows that exercise can improve function, quality of life, and
decrease fatigue in individuals with a cancer diagnosis. Exercise has also been found to
be safe and improve function in patients with cancer who are critically ill with low blood
count values.
Current research regarding decisions on when to mobilize patients in the intensive
care unit (ICU) is limited. Mobility interventions for patients in the ICU have not
received much attention. Despite the knowledge that exercise is beneficial for decreasing
the effects of immobility, and that exercise helps patients return to previous level of
functioning, the exact manner and guidelines regarding when to administer rehab
treatment or safely administer mobility maneuvers to critically ill patients is not well
understood.6

Research shows improvement in mood, coordination, muscle strength,

balance, and work tolerance when critically ill patients receive mobility therapy.6 Several
publications have shown a benefit to early exercise therapies for inpatient populations.18
Inpatient rehab programs have been shown to benefit exercise capacity, lipid profiles,
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weight changes, autonomic function, subsequent hospitalization costs, and cardiovascular
morbidity and mortality.25,19 Inpatients receiving early rehab therapy reported a greater
than 50% reduction in depressive symptoms, and also demonstrated better function in
activities of daily living (ADLs) after only one month.
Other existing views advise that exercise should only be initiated at the point of
complete remission from cancer.17 Although valuable to acknowledge prevailing advice
for patients to rest and avoid intense exercise, this should not outweigh the risks of
deconditioning and immobilization. A pilot study by Baker et al.18 showed that 31
critically ill patients who took part in 69 rehab sessions were mobilized without any
deterioration in their health status. Patients were deemed suitable for therapy based on
guidelines set by Stiller et al.6 These guidelines for mobilizing critically ill patients
recommend that hemoglobin values be stable and >7g/dL, platelet counts stable and
>20,000/microL and white blood cell counts between 4,300-10,800/mm3. If any blood
value is not within these guidelines, appropriateness of mobilization should be discussed
with another physical therapist or other medical professionals before deferment.7,22
Few research studies measure blood values during exercise interventions for
patients with cancer. The research is even more limited when looking at studies that
exercised patients with very low blood counts. We did not find any study that exercised
patients with hemoglobin, platelets, or white blood cell counts much below recommended
guidelines as set by the APTA. A study by Elter et al.17 looked at the effects of aerobic
training on patients with a cancer diagnosis undergoing high dose chemotherapy. The
aerobic exercise consisted of three weekly bike ergometer trainings of 15-30 minutes at
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sub-maximal intensity. The researchers monitored blood values and set guidelines as for
when to discontinue treatment. When patients’ platelets were >20,000/microL without
any sign of bleeding, they were allowed to proceed with the program but were under
special precautions that blood pressure not exceed 170/100. Patients’ whose platelets
reached <10,000/microL or hemoglobin levels <8g/dL necessitated a blood or platelet
transfusion prior to continuation of aerobic training. By the end of the study, all trained
subjects performed better on the final test. Sub-maximal endurance capacity also showed
significant improvements for the training group during the period of hospitalization.
Throughout the study, median platelet count was 27,000/microL with a minimal count of
8,000/microL. Hemoglobin values on average were 9.2g/dL with minimal blood values
reaching 7.7g/dL.
Patients participating in aerobic exercise training were found to be more likely to
complete the full intended number of chemotherapeutic treatments as compared to
untrained patients.17 The researchers in this study did not use previously set blood value
guidelines for the continuation of physical activity. Instead they only judged patients’
ability to participate in exercise based on clinical signs of bleeding. None of the patients
in the study with platelet counts <10,000/microL or hemoglobin values <8g/dL suffered
bleeding or adverse reactions to exercise. Patients with severe active infection were not
allowed to participate in exercise training. This study illustrated the positive effects
exercise has on patients with cancer undergoing high dose chemotherapy. It also showed
that for patients with cytopenia, aerobic exercise was safe and did not cause increase in
bleeding.17
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Dimeo et al.21 looked at the effects of an interval training program on patients
with cancer receiving high dose chemotherapy. Sixteen patients participated in a rehab
program for six weeks and another 16 patients served as controls. Exercise treatments
were held for 15-30 minutes at an intensity of approximately 80% of heart rate
maximum. Physical function, cardiac function, and hemoglobin concentrations were
measured at the time of discharge from the hospital and then again seven weeks later
after the training intervention. At baseline, hemoglobin levels were 10±1.4g/dL for the
training group and 10±1.2g/dL for the control group. After seven weeks, hemoglobin
concentration was significantly higher in the training group, 13±1.0g/dL versus
12±1.4g/dL for the control group. There were no cardiac, infectious, or bleeding
complications seen throughout the training program. To reduce the risk of bleeding or
infections in the training group, patients in this study were not allowed to start training
until their platelet counts were >20,000/microL and leukocyte levels >1.5x109/mm3. No
adverse reactions were noted for any of the patients in the training group. Anemia was
not a contraindication for inclusion in the training program. The researchers felt it was
important to allow patients with anemia to participate in training due to the positive
effects exercise has been shown to have on improving physical performance and
hemoglobin levels in patients with cancer. Many patients with cancer suffer from anemia
so defining this condition as a contraindication for the exercise program would exclude
many patients from rehab at a time when they might benefit from it most.21 The exercise
program was shown to partially improve anemia in patients. All patients in the study had
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stem cell transplantation, and the effect the aerobic training program would have had on
the patients without stem cell transplantation remains unknown.
A study by Dimeo et al.14 looked at the effects of aerobic exercise on patients with
cancer. The treatment group took part in daily aerobic exercise programs consisting of
biking with a bed ergometer for one minute at an intensity level of at least 50% of cardiac
reserve. This was repeated 15 times with one minute breaks between exercise bouts for a
total of 30 minutes each day. Patients with a fever >37.5 degrees Celsius or platelets
<10x109/L were instructed to discontinue training until their fevers went away.
Individuals who continued to have severe infections or multiple complications were not
allowed to resume training. Patients were transfused when hemoglobin blood counts were
<8g/dL or when platelets were <20X109/L. This study found the training group to have
shorter duration of neutropenia 6.6±1.5 days versus the control group 7.6±1.6 days. The
training group also required less platelet transfusions and was found to have shorter
duration of thrombopenia (platelets <50x109/L) 10.9±3 days versus the control group
12.4±3.7 days. There were no complications in the patients who participated in rehab
immediately after completing high dose chemotherapy. The aerobic exercise improved
physical performance and reduced fatigue in patients. The researchers concluded that the
severe loss of function often observed after high dose chemotherapy can be partially
prevented with rehab exercises.
Stiller et al.22 also looked at the effects of mobilizing critically ill patients with
low blood values. Patients’ baseline hemoglobin concentration had a mean value of
9.1±1.0g/dL and a range of 7-15.8g/dL. Baseline platelet values had a mean value of
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301,000/microL with a range of 42,000-742,000/microL. White blood cell counts ranged
from 4,400-20,100/mm3 with a mean baseline value of 10,500/mm3.

In two of 69

sessions for mobilization, patients reported feeling dizzy but did not require any direct
medical intervention, nor did it limit the treatment session. No change in the severity or
frequency of cardiac arrhythmias was noted during mobilizations.22 In three of 69
occasions, a deterioration in patients’ condition required intervention.

All three

occasions were due to a fall in SpO2. Although there was a low incidence of problems
during the treatment mobilizations a comprehensive screening process was used to select
appropriate patients for mobilization. The guidelines set by Stiller et al.13 were used as
parameters for mobilization. These included hemoglobin values stable and >7g/dL,
platelet counts stable and >20,000/microL and white blood cell counts between 4,30010,800/mm3.

The low incidence of adverse reactions in this study suggests that

guidelines by Stiller et al.13 and utilizing clinical judgment to assist in deciding
appropriateness of critically ill patients for mobilization is safe.
In another study, 20 patients with cancer undergoing bone marrow transplantation
participated in a rehab program. The program consisted of treadmill walking according to
an interval training protocol for six weeks. Each treatment session was approximately 30
minutes at an intensity 80% of heart rate maximum.23 Inclusion criteria for the study
included sustained platelet counts >20,000/microL, absolute neutrophil count of 1x109,
and stable clinical condition. Throughout the six week training program, physical
performance improved and no cardiac, infectious, or bleeding adverse reactions occurred.
All patients reached a cardiovascular performance level that equates that of carrying out
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all basic activities of daily living. Other studies have reported impaired physical
functioning by patients participating in training programs after receiving bone marrow
transplantation. No such evidence of this was found in this study, and instead, Dimeo et
al.23 observed patients gaining self-confidence, improved physical functioning, and
improved mood, resulting in higher levels of independence and improved quality of life.
No evidence currently exists on the safety of exercise for pediatric patients with
chronically low blood values due to cancer treatment. However, given the evidence that
exercise may be appropriate for these patients, we decided to examine the safety of
physical therapy treatment to see if any critical incidents occur when children with low
blood values exercise versus children with normal lab values. Specifically, we looked at
hemoglobin, white blood cell count, and platelet count in relation to critical events for a
population of children receiving physical therapy at one site where the current practice is
to set exercise parameters based on the symptom assessments of the attending physical
therapists and not on the blood values guidelines. This situation gives us the unique
ability to look at the safety of exercise in patients who may have chronically low blood
values but are clinically stable.

Chapter II
Methods
For this study a retrospective chart review was performed. The subjects were a
sample of 73 consecutive children diagnosed with a non-CNS cancer. The children
ranged in age from 3 to 18 years and had received physical therapy while undergoing
chemotherapy treatment at Children’s Hospitals and Clinics of Minnesota. Subjects who
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met the inclusion criteria and did not meet the exclusion criteria were selected
consecutively by the lead researcher from the Children’s Hospitals and Clinics of
Minnesota pediatric oncology database. The inclusion criteria for subjects included a
current diagnosis of a non-CNS cancer, a chemotherapy treatment time greater than or
equal to two months (to ensure likelihood of chronic low blood values), were between 3
and 18 years of age, and had at least two sessions of physical therapy from Children
Hospitals and Clinics of Minnesota. Subjects were excluded if they did not meet the
inclusion criteria, had a previously diagnosed cardiac disorder, or if they had undergone a
recent surgical resection.
For each subject, up to four physical therapy (PT) visits were identified in the
electronic medical record and examined until 201 chart reviews were completed. Only
physical therapy visits within 24 hours of a complete blood count were reviewed. The
patient’s hemoglobin, platelets, and white blood cell values were recorded once a
qualifying (within 24 hours of a CBC) PT visit was identified, along with the type of
interventions performed, the patient’s subjective symptoms, and any modifications made
by the therapist during treatment. The electronic medical record was then examined for
two days following the PT visit for any critical incidents that may have occurred. The
areas of the chart reviewed included hematology/oncology notes, nursing notes, and
emergency department notes.

Critical incidents were defined as: syncope, cardiac

arrhythmia, low blood pressure, oxygen saturation <90%, shortness of breath,
bradycardia, tachycardia (based on age-adjusted normal values), falls, pain, impaired skin
integrity, fever, and negative patient subjective complaints. (See Appendix A)
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Chapter III
Analysis/Results
Once the data was gathered, a Chi-square analysis was used to look for a
correlation between critical incidents and chronically low hemoglobin, platelets, and
white blood cells. For cases where Chi-square cells were <5, a Fisher exact test of
significance was used. Risk ratio was also calculated in order to determine the relative
risk of a critical incident following physical therapy intervention when subjects’ blood
values were low as compared to subjects with normal blood values.
The retrospective chart review included 201 physical therapy treatment sessions
for a total of 73 patients. No more than four physical therapy sessions per child were
analyzed with a mean number of 2.8 visits per child. The mean age was 9.5 years old and
ranged from 3-18 years. The three most common cancer diagnoses were leukemia (60%),
solid tumors (32%), and lymphoma (8%). Forty-five percent of the subjects were male
and 55% were female. Approximately 14% of the subjects had had either a red blood cell
or platelet transfusion in the past week. Fifteen percent of the patients were being seen for
inpatient physical therapy, whereas 85.5% were seen in an outpatient setting.
The mean blood values for hemoglobin, platelets, and white blood cells taken
within 24 hours of a patient’s physical therapy treatment session were found (Table 1).
The mean hemoglobin for this patient population was found to be 10.5 g/dL. The mean
platelet value was 226.6 x103/microL, and the mean white blood cell value was 3.5
x103/mm3. According to the age adjusted blood count reference values from Children’s
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Hospitals and Clinics of Minnesota, the percentages of subjects whose values were
normal versus abnormal were calculated (Table 1).

Table 1.
Mean blood values for the examined pediatric oncology population and
percentages of normal and abnormal blood lab values (n=201)

Abnormal hemoglobin and platelet values were divided further according to
APTA guidelines for exercise. Ten percent of the patients had hemoglobin values of <8
and 5.5% of the subjects had platelet values <20,000 indicating no exercise permitted. It
is important to note the low percentages of patients with normal blood values and the
very high percentages of patients with abnormal blood values in this pediatric oncology
population. More than two thirds of the pediatric oncology population receiving physical
therapy at Children’s Hospitals and Clinics of Minnesota had abnormal blood values.
Very few patients had such low blood values that no exercise would have been
recommended by the APTA guidelines.
Of the 201 patient charts reviewed, there were a total of thirteen critical incidents
that occurred within two days following a physical therapy treatment session.
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Approximately 6.5% of the patient population actually had a critical incident, as defined
by the research study. The thirteen events included seven events of tachycardia, three
subjective complaints of pain, two fevers, and one fall that occurred during the physical
therapy session. There were no episodes of arrhythmia, syncope, hypotension, oxygen desaturation less than 90%, shortness of breath, major bleeds, or skin integrity issues.
Having a critical incident was very rare, and those that did occur were not severe enough
to institute major medical attention. Seventy-six percent had no documented adverse
symptoms during their physical therapy session. The remaining 24% had complaints of
fatigue, pain, nausea, and/or shortness of breath.

Physical therapy was modified

accordingly in 5.5% of patient cases. These symptoms were not defined as critical
incidents.
There was very little difference in the percentages of patients experiencing critical
events when blood values were normal as compared to abnormal blood values (Figure 1).
For example, 3% of patients with normal platelet values had a critical event, whereas 4%
of patients with abnormal platelet values had an event. There was only a 6% difference in
critical events between subjects with normal hemoglobin values and abnormal values. A
Fisher’s exact test showed no significant relationship between low hemoglobin, low
platelets, or low white blood cells and the number of critical incidents. Chi-Square was
2.56 (p= 0.196), 0.198 (p=0.776), and 0.501 (p=0.444) for low hemoglobin, low platelets,
and low white blood cells, respectively.
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Figure 1.
Distribution of Critical Events in Patients with Normal versus
Abnormal Blood Values

The risk ratio for low hemoglobin was 4.3 (CI= 0.58-32.20) (Figure 2). For low
platelets the risk ratio was 0.79 (CI= 0.29-2.20). The risk ratio for low white blood cell
count was 0.64 (CI= 0.19-2.17). All confidence intervals include one, and therefore
demonstrate there may not be an increased risk of critical event when blood values are
low versus normal blood values (Figure 2).
Figure 2.
Risk Ratios of Critical Incidents in Patients with Low Blood Values
versus Normal Blood Values with Respective Confidence Intervals
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The distribution of critical incidents for normal and abnormal hemoglobin values
was also analyzed (Figure 3). For patients whose hemoglobin values were within normal
age adjusted ranges, 2% had a critical event. For patients with an abnormal hemoglobin
value yet >10, 8% of subjects had a critical event. For hemoglobin values 8-10, 6.5% had
a critical event. For hemoglobin <8, indicating no exercise permitted, 20% had a critical
event. No significant differences were found in the way confidence intervals were
distributed for platelets (X2=5.795, p= 0.122). A power analysis indicated insufficient
power to be confident that no relationship exists between critical incidents and low
hemoglobin.
Figure 3.
Distribution of Critical Events for Normal and Abnormal
Hemoglobin Values
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The distribution of critical events for normal and abnormal platelet values found
that 8% of patients whose platelets were normal had a critical event (Figure 4). For
patients with abnormal platelets, yet >50,000, 7% had a critical event. For values 20,00050,000, zero out of the four participants had a critical event. For patients with platelets
<20,000, indicating no exercise permitted, zero of the seven had a critical event. No
significant differences were found in the way confidence intervals were distributed for
platelets (X2=0.974, p= 0.808) (Figure 4).
Figure 4.
Distribution of Critical Events for Normal and Abnormal Platelet
Values

For patients with low platelet blood values, it is recommended that physical
therapy avoid activities such as stretching due to the decreased ability of the patient’s
blood to clot. When patients’ platelet values were abnormally low, there was no
significant difference found in the distribution of critical incidents in patients with
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stretching versus no stretching (X2=0.769, p= 0.476) (Table 2). Four percent of patients
with abnormal platelets and were stretched had a critical event, whereas 8% of patients
without stretching during physical therapy had a critical event. Another common concern
is for patients with low hemoglobin values performing endurance exercises.

It is

recommended that physical therapy avoid endurance exercises when patients’
hemoglobin values are abnormally low due to increased risk of fatigue, tachycardia, and
the increased oxygen demands placed on the body’s tissues. There was no significant
difference found in the distribution of critical incidents in patients with abnormally low
hemoglobin when endurance exercises were done versus no endurance exercises
(X2=0.066, p= 1.00) (Table 3). Eight percent of patients with abnormal hemoglobin
values who performed endurance exercises had a critical event, whereas 9% of patients
without endurance exercises during physical therapy had a critical event.
Table 2.
Patients with abnormal platelet values. Distribution of
critical events when stretching versus no stretching was done
during PT.

Table 3.
Patients with abnormal hemoglobin values. Distribution of critical
events when endurance exercises versus no endurance exercises
were done during PT.

25

The correlation between certain sub-groups of patients and critical incidents was
also analyzed. There were no relationships found between critical incidents and type of
cancer (X2=1.87, p=0.39) or age (X2=0.104, p=0.75) of the patient. The correlation
between the types of physical therapy exercise performed was also analyzed for
relationship with critical events. There were no statistically significant relationships
(p<0.05) found between critical incidents and interventions tested. Interventions included
strength training with resistance (X2=0.686, p=0.404), strength training with jumping
(X2=2.093, p=0.247), gait training (X2=0.329, p=0.593), endurance (X2=0.124, p=1.0),
balance (X2=0.163, p=0.777), and stretching (X2=0.492, p=0.576).

Chapter IV
Discussion
Chi-Square analyses indicated no significant correlation between critical incidents
and chronically low hemoglobin, low platelets, or low white blood cells. High
percentages of patients in the pediatric oncology population have chronically low blood
values. According to Stiller et al.6 chronically low blood values for a particular patient
should be treated differently than an acute change. If a patient has been living stably with
chronically abnormal lab values it has been the practice of many physicians to allow
physical activity in order to prevent the deleterious results of bed rest and inactivity.
These deleterious effects include: muscle weakness, decreased muscle endurance,
negative nitrogen balance, pneumonia, thrombosis, kidney stones, increased diuresis,
orthostatic hypotension, cardiovascular deconditioning, skin breakdown, depression,
fatigue, and decreased quality of life.10 Therefore it is important to weigh the possible
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risks and benefits of exercising a patient with abnormal blood values.

In the current

study, physical therapy was found to be very safe when using symptom based guidelines
for activity in children being treated for cancer with a very low percentage of critical
events.
Of the thirteen critical incidents that did occur, all events were minor with
approximately 50% having symptoms of tachycardia. Tachycardia happens to be a
common symptom of low hemoglobin, and its occurrence is somewhat expected and does
not merit discontinuing physical therapy. No major events such as heart arrhythmias,
syncope, hypotension, or major bleeds occurred in any of the patients receiving physical
therapy treatment.
There was also no increased risk of critical events in children with low platelets or
low white blood cells when compared to normal blood values with risk ratios 0.79 and
0.64 respectively. An increased risk ratio of 4.3 was noted for critical incidents in
subjects with low hemoglobin as compared to normal hemoglobin values. Despite an
increased risk ratio, a confidence interval of 0.58-32.30 indicates patients had a decreased
risk of event, no additional risk, or an increased risk of critical event. We cannot be
confident that the risk ratio for hemoglobin is significant. A power analysis for
hemoglobin indicated insufficient number of subjects to be confident in the finding of no
relationship.
A study by Dimeo et al.14 found similar results when looking at the effects of
aerobic exercise on adult patients with cancer. The treatment group took part in daily
aerobic exercise programs consisting of biking with a bed ergometer for one minute at an
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intensity level of at least 50% of cardiac reserve. This was repeated fifteen times with
one minute breaks between exercise bouts for a total of 30 minutes each day. There were
no complications in the condition of patients who participated in rehab immediately after
completing high dose chemotherapy. The aerobic exercise improved physical
performance and reduced fatigue in patients. The researchers concluded that the severe
loss of function often observed after high dose chemotherapy can be partially prevented
with rehab exercises.
Stiller et al.22 looked at the effects of mobilizing ill patients with low blood
values. Patients’ baseline mean hemoglobin values were 9.1 g/dL and ranged from 715.8g/dL. Baseline platelet values had a mean value of 301,000/microL and ranged from
42,000-742,000/microL. During 2 of 69 mobilization sessions, patients reported feeling
dizzy but did not require any direct medical intervention. In 3 of 69 occasions, a
deterioration in patients’ condition required intervention. All three occasions were due to
a fall in SpO2. There was no change in the severity or frequency of cardiac arrhythmias
noted during mobilizations.
In an additional study by Dimeo et al.23 patients with cancer undergoing bone
marrow transplantation participated in a rehab program. The program consisted of
treadmill walking according to an interval training protocol for six weeks. Throughout
the six week training program, physical performance improved and no cardiac, infectious,
or bleeding adverse reactions occurred. No such evidence of impaired physical
functioning was found. Instead, patients gained self-confidence, improved physical
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functioning, and had less depressive moods resulting in higher levels of independence
and improved quality of life.
In the current study, there was also no significant relationship between critical
incidents and specific sub-populations of patients such as type of cancer, age, or type of
physical therapy exercise. When patients’ platelet values were abnormally low, there was
no significant difference found in the distribution of critical incidents in patients with
stretching versus no stretching.

There was no significant difference found in the

distribution of critical incidents in patients with abnormally low hemoglobin when
endurance exercises were done versus no endurance exercises.
These results of the current study suggest the use of a symptom-based approach in
determining appropriateness for physical therapy may be utilized in pediatric populations
experiencing chronically low blood values.

An additional screening process for

determining patients appropriate for physical therapy has been proposed by Stiller et. al.13
The guidelines recommend that hemoglobin values be stable and >7g/dL, platelet counts
stable and >20,000/microL and white blood cell counts between 4,300-10,800/mm3. If
any blood value is not within these guidelines, appropriateness of mobilization should be
discussed with another physical therapist or medical professional before deferment.
Therapists may be able to decide if a patient is safe for physical therapy based on
additional objective and/or subjective factors. Objective factors include heart rate, blood
pressure, cardiac status, oxygenation, respiratory pattern, or blood glucose levels.
Subjective symptoms such as the patient’s facial expression, emotional state, pain,
anxiety, pallor, rate of perceived exertion, and/or diaphoresis may be used for
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determining patients’ appropriateness for physical activity.

These guidelines in

conjunction with clinical judgment, experience, and current APTA hematological
guidelines may be utilized in populations experiencing chronically low blood values.
Limitations of this study include the small sample size. Of the 201 total charts
reviewed, there were only 13 critical incidents identified.

Having so few critical

incidents makes it difficult to find statistically significant correlations. Only 9.8% of the
patients receiving physical therapy had hemoglobin values <8 and only 5.5% of patients
had platelets <20,000. Conducting a larger study with more participants may result in
more subjects with extreme low blood values allowing researchers to investigate the
relationship between physical therapy and critical incidents. Also, if we are suggesting a
symptom-based approach to determining level of activity during physical therapy, it
would be interesting to note the types of modifications physical therapists made to
treatment sessions when patients’ blood values were low. Although efforts were made to
record any changes to physical therapy treatment sessions, all modifications may not
have been fully documented limiting our ability to know what specific changes actually
minimized the occurrence of critical events. In addition, it is possible we may not have
had access to all emergency medical files from outside hospitals. Although one can
expect a phone call would be made from the outside hospital and placed in the child’s
medical record, we cannot be completely confident we were able to record all critical
incidents.
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Chapter V
Conclusion
The results of this study support our original hypothesis. There was no difference
in the amount of critical incidents occurring within two days after physical therapy in
pediatric oncology patients with chronically low blood values versus normal blood
values. Physical therapy was found to be safe for children experiencing chronically low
blood values from chemotherapy treatment when the therapist used symptoms as a
guideline for treatment parameters. Additionally, when analyzed, there were no subpopulations of patients found to be at an increased risk of critical events. The evidence
suggests a symptom-based approach in determining appropriateness for physical therapy
may be utilized in populations experiencing chronically low blood values. Future studies
with larger samples sizes are needed to ascertain whether these findings are consistent
and statistically significant.
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Appendix A
Patient ID:
PT Treatment Date:
Age:
Gender: M / F
Type of cancer:
Time in Oncology Treatment:
Transfusions in last week: _____RBC _____Platelets
Physical Therapy seen as: _____ Inpatient _____ Outpatient

(months)

Lab Values Date and Time: __________
Hemoglobin: ___________
Platelets: ____________
WBC Count:_____________
Physical Therapy Interventions:
_____ Strength Training, if yes  Resistance given Yes / No
_____ Gait Training
_____ Endurance Exercise, if yes  Running Yes / No
_____ Balance Training
_____ Stretching, if yes  Joint Mobilization Yes / No
_____ Other:

circle type: weights, bands, manual
Pilates, jumping, closed chain

PT recorded modified due to symptoms: ____ Yes ____ No
Symptoms noted by PT:
_____ Paleness
_____Fatigue
_____ Headache
_____ Shortness of breath
_____ Increased HR
_____ Lethargy
_____ Bruising
_____Bleeding of gums reported
_____ Parent reporting change in behavior
_____ Other: _________________
_____ Other: _________________
Date and Time of Physical
Therapy:

Critical Incidences
during PT

Critical Incidences
w/in 2 hours after PT

Critical Incidences 1
day after PT

Critical
Incidences 2 days
after PT

Syncope

Yes / No

Yes / No

Yes / No

Yes / No

Cardiac arrhythmia

Yes / No

Yes / No

Yes / No

Yes / No

Low blood pressure

Yes / No BP:

Yes / No BP:

Yes / No BP:

Yes / No BP:

SpO2 <90%

Yes / No

Yes / No

Yes / No

Yes / No

Shortness of Breath
Heart Rate at rest:
Bradycardia
Tachycardia
(use age app. Values)

Yes / No

Yes / No

Yes / No

Yes / No

Normal
Brady / Tachy

Normal
Brady / Tachy

Normal
Brady / Tachy

Normal
Brady / Tachy

Falls

Yes / No

Yes / No

Yes / No

Yes / No

Description of fall:

Description of fall:

Description of fall:

Description of fall:

Yes / No
Temp:

Yes / No
Temp:

Yes / No
Temp:

Yes / No
Temp:

Pain Rating 0-10
Skin integrity (ecchymosis,
breakdown, erythema)

Fever
Pt. Subjective complaints
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